Surveillance and evaluation of ventilator-associated events as per Centers for Disease Control and Prevention guidelines

Abstract

While ventilator-associated pneumonia (VAP) can affect all patients ventilated for >2 days in an ICU, an issue during the last two decades has been identification of a universally accepted definition. The Centers for Disease Control and Prevention (CDC) in Atlanta, GA, USA, have designed a new surveillance paradigm aiming to increase the objectivity of VAE diagnosis ranging from ventilator-associated condition (VAC), infective VAC to possible and probable VAP [1]. We assessed the feasibility and accessibility of the audit tool developed from the CDC guidelines as a marker of quality assurance.

Related Papers

• → Audit in infection control(2005)24 cited
• → CHLORHEXIDINE REDUCES VENTILATOR ASSOCIATED PNEUMONIA (VAP) IN MECHANICALLY VENTILATED ICU ADULTS.(2006)3 cited
• [Value of the clinical pulmonary infection score for the prognosis of ventilator-associated pneumonia].(2006)
• → The Incidence of VAP after VAP Bundle Intervention Among Patients with Mechanical Ventilation(2015)
• Ventilator-associated pneumonia：VAPと ventilator-associated events：VAEサーベイランス(2013)